Weight-Loss Drug Zepbound Faces Supply Issues
Another popular weight-loss drug is in short supply. Doses of tirzepatide (Zepbound) are few and far between, experts told MedPage Today, although the injectable has not been listed in the FDA Drug Shortage Database as of today. Another version of tirzepatide, for type 2 diabetes (Mounjaro), has been on the FDA shortage list since December […]